Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Autism spectrum disorder (ASD), encompassing impaired communication and social interaction, and repetitive stereotypic behavior and language, affects 1–2% of predominantly male individuals and is an enormous medical and economic problem for which there is no documented, mechanism-based treatment.
In a placebo-controlled, randomized, double-blind clinical trial, daily oral administration for 18 weeks of the phytochemical sulforaphane (derived from broccoli sprouts) to 29 young men with ASD substantially (and reversibly) improved behavior compared with 15 placebo recipients. Behavior was quantified by both parents/caregivers and physicians by three widely accepted measures.
READ FULL ARTICLE
From Science Alert
